OPALGYNE 0.1 %, vaginal solution in a single-dose container 2 single-dose containers of 140 ml
Active ingredients: Benzydamine hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Solution2 single-dose containers of 140 mlvaginale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- OPALGYNE 0,1 %, solution vaginale en récipient unidose
- Pharmaceutical form
- solution
- Route of administration
- vaginale
- Presentation description
- 2 récipient(s) unidose(s) de 140 ml avec canule(s) polyéthylène
- Marketing authorisation holder
- INNOTECH INTERNATIONAL
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Jul 2022
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65687211CIP73296627CIP133400932966271Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BENZYDAMINE (CHLORHYDRATE DE)solution | 100 mg · 100 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.